Vorinostat
規格
149647-78-9CAS番号
682-505-1EC番号
N'-hydroxy-N-phenyloctanediamideIUPAC名
C14H20N2O3化学式
264.32 g/mol分子量
Vorinostat; 149647-78-9; SAHA; suberoylanilide hydroxamic acid; N-hydroxy-N'-phenyloctanediamide; Zolinza; Suberanilohydroxamic acid; N1-hydroxy-N8-phenyloctanediamide; MK-0683; MK0683; Octanediamide, N-hydroxy-N'-phenyl-; N'-hydroxy-N-phenyloctanediamide; OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE; vorinostatum; NSC-701852; DTXSID6041133; NSC-748799; NSC-759852; MK 0683; 58IFB293JI; NSC701852; DTXCID4021133; CHEBI:45716; NHNPODA; suberoyl anilide hydroxamic acid; N Hydroxy N' phenyloctanediamide; N1 Hydroxy N8 phenyloctanediamide; 18F-suberoylanilide hydroxamic acid; 18F Suberoylanilide Hydroxamic Acid; RefChem:389361; L01XX38; MSK-390; L-001079038; 682-505-1; Vorinostat (SAHA, MK0683); CCRIS 8456; N-Hyrdroxy-N'-phenyloctanediamide; MFCD00945317; Vorinostat (SAHA); SHH; CHEMBL98; 8-(hydroxyamino)-8-oxo-N-phenyl-octanamide; n-hydroxy-n'-phenyl-octanediamide; WIN64652; s1047; Octanediamide, N1-hydroxy-N8-phenyl-; SAHA cpd; NCGC00168085-01; NCGC00168085-02; Vorinostat [USAN]; Zolinza (TN) (Merck); N-hydroxy-N'-phenyl-octane-1,8-diotic acid diamide; Vorinostat MSD; Vorinostat(SAHA); SMR000486344; Zolinza (TN); CAS-149647-78-9; SR-05000000373; Vorinostat (JAN/USAN); Vorinostat [USAN:INN]; UNII-58IFB293JI; SKI390; HSDB 7930; 4lxz; Zolinza; SAHA; Vorinostat (GMP); SAHA, Suberoylanilide hydroxamic acid; Vorinostat (SAHA)?; Vorinostat (Standard); 1zz1; VORINOSTAT [MI]; TNFa + SAHA; SW-064652; VORINOSTAT [INN]; VORINOSTAT [JAN]; VORINOSTAT [VANDF]; cid_5311; SCHEMBL9018; VORINOSTAT [MART.]; VORINOSTAT [WHO-DD]; Suberoylanilidehydroxamic Acid; MLS001065855; MLS006011941; Suberoylanilide-hydroxamic acid; GTPL6852; orb1226185; orb1308090; VORINOSTAT [ORANGE BOOK]; BDBM19149; Vorinostat - Bio-X trade mark; Vorinostat (SAHA; MK0683); SUBERANILOHYDROXAMINIC ACID; 1t69; N-hydroxy-N''-phenyloctanediamide; GLXC-05791; HMS2219L20; HMS3264D20; HMS3327C12; HMS3426G03; HMS3650D09; HMS3654G11; HMS3715E22; HMS3745M03; HMS5079I07; HMS6019F05; Pharmakon1600-01502267; EX-A2745; HVB74948; SAHA, >=98% (HPLC); Vorinostat,SAHA,Zolinza,MK-0683; Tox21_112605; Tox21_113623; Vorinostat,CAS:149647-78-9; EBC-11271; HB1396; HY-10221G; HY-10221R; NSC748799; NSC759852; Octanediamide, N1-hydroxy-N8-phenyl; SK1390; AKOS015966648; Tox21_112605_1; AC-1923; CCG-208659; CS-0589; DB02546; DG-0025; FH15949; NSC 701852; NSC 748799; NSC 759852; SB17319; N~1~-Hydroxy-N~8~-phenyloctanediamide; NCGC00168085-03; NCGC00168085-04; NCGC00168085-05; NCGC00168085-13; NCGC00168085-21; BP-25652; BP-30216; BV164560; HY-10221; SY009383; H1388; NS00068618; SW199536-4; V5734; D06320; EN300-120641; M06303; AB00375377-07; AB00375377-08; AB00375377-09; AB01644613_25; Q905901; Vorinostat, SAHA, suberoylanilide hydroxamic acid; SR-05000000373-2; SR-05000000373-6; SR-05000000373-8; BRD-K81418486-001-01-2; BRD-K81418486-001-10-3; BRD-K81418486-001-12-9; BRD-K81418486-001-13-7; BRD-K81418486-001-17-8; BRD-K81418486-001-18-6; BRD-K81418486-001-44-2; BRD-K81418486-001-47-5; Z1530532755; N-Hydroxy-N inverted exclamation mark -phenyloctanediamide; 1227736-21-1別名
